Asian Spectator

Men's Weekly

.

Jemincare Announces the Exclusive License of the Kras Inhibito...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
SHANGHAI, Nov. 30, 2021 /PRNewswire-AsiaNet/ -- Jemincare, a leading pharmaceutical company from China, announced today its wholly owned subsidiary company, Shanghai Jemincare Pharmaceutical Co., Ltd., had licensed exclusive worldwide ex-China rights to the Kras inhibitor, JMKX1899, to HUYABIO ...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Buying Managed IT Services in Australia (Without Paying for Surprises)

Managed IT usually becomes a serious conversation when interruptions start affecting delivery. For most Australian businesses in the 7–100 staff range, that shift happens quietly.  For example, clo...

Ramadan jadi peluang ‘brand’ melejit: Intip strategi Marjan, Promag, dan sarung Atlas

● Ramadan secara tradisi mendorong terjadinya peningkatan konsumsi masyarakat yang cukup signifikan.● Karena itu, Ramadan kerap dijadikan momen untuk meningkatkan omzet bagi brand.● ...

4 ribu ASN dijadikan komponen cadangan: Keharusan atau militerisasi?

Seorang prajurit TNI membawa peluru kaliber saat mengikuti latihan militer di Jawa Timur.Lonewolfgher_06/Shutterstock● Pelibatan ASN sebagai Komponen Cadangan dapat merusak supremasi sipil.χ...